Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board - taking

Related Keywords

Switzerland , Montreal , Quebec , Canada , France , San Francisco , California , United States , Chiron , Centre , Paris , France General , Allschwil , Switzerland General , Japan , Netherlands , French , America , Swiss , Sandy Mahatme , Martine Clozel , Alberto Gimona , Bart Filius , Mathieu Simon , Andrewc Weiss , Arno Groenewoud , Jean Paul Clozel , Peter Kellogg , Sophie Kornowski , Srishti Gupta , Felix Ehrat , Julien Gander , University Of Montreal , Roche Research Prize , Business Administration , Business School , Nyenrode University , Head Of Investor Relations Corporate Communications , Audit Committee Of Proqr Therapeutics , Johnson , Head Of Global Clinical Development , Arthurd Little , Business Development , Idorsia Pharmaceuticals Ltd , Swiss Exchange , Idorsia Ltd , Roche Ltd , Idorsia Executive Committee , University Of California , Nasdaq , Paul Clozel , Lead Independent , Annual General Meeting , Chief Executive Officer , Chief Financial Officer , Group General Counsel , Chief Scientific Officer , Global Clinical Development , Group General , Lead Independent Director , Roche Cardiovascular Drug Discovery , Technical Innovation , Pierre Fabre , Chiron Investments , Chief Operating Officer , Audit Committee , Vice President , North America , Investor Relations , Pharmaceuticals Ltd , Ihr Portfolio ,